Loading stock data…
SRX Global Inc. (SRXH)
$1.58+0.07 (+4.64%)
Market ClosedLast close Sep 8
SRX Global Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SRX Global Inc. in the Consumer Defensive sector is trading at $1.58 with a market capitalization of $32M. The stock is currently near its 52-week low of $0.96, remaining 80.7% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 35) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.44M↑ | $2.81M↑ | -$34.55M | — | $7.16M |
| Gross Profit | $1.27M↑ | $1.05M↑ | -$8.77M | — | $2.38M |
| Operating Income | -$1.82M↑ | -$3.79M↓ | $18.08M | — | -$1.09M |
| Net Income | -$6.38M↑ | -$8.61M↑ | -$15.26M | — | -$964,000 |
Peer Comparison
Fundamentals
SRX Global Inc. operates an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. It leverages proprietary technology, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$32.02M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-24.05%
Volume
Today's trading volume
340,646
Recent News
SRX Global Inc (SRXH) (Q3 2026) Earnings Call Highlights: Strategic EMJX Acquisition and Record ...
SRX Global Inc (SRXH) reports a 27% revenue increase and 52% cost reduction, while advancing its AI-driven digital asset strategy despite ongoing profitability challenges.
SRX Global Acquires Stake in Vistagen Therapeutics
SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).
SRXH Stock Falls Premarket Ahead Of Eric Jackson's Fireside Chat — Traders Brace For Buyback Clues And CEO Spotlight
The discussion is expected to cover the EMJX acquisition, future strategy and responsibilities.
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision
SRx Health, which is merging with EMJ Crypto Technologies, said EMJ’s proprietary operating system used quantitative models and artificial intelligence to pick Optimi Health as an investment opportunity.
Why Is Opendoor (OPEN) Stock Rocketing Higher Today
Shares of technology real estate company Opendoor (NASDAQ:OPEN) jumped 7.5% in the afternoon session after SRx Health Solutions, along with its merger partner EMJ Crypto Technologies, announced it increased its investment in the company.